Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial

Table 2 Incontinence episode frequency.

Treatment group (N)†	Time point	n‡	Median IEF/week	Median percent change from baseline	95% CI for median percent change in IEF	P
Placebo (61)	Baseline	59	14.00
	Endpoint		6.25
	Change		-5.63	-42.56	(-56.79,-33.89)
Duloxetine (60)	Baseline	46	13.46
	Endpoint		4.12
	Change		-7.25	-69.98	(-81.25,-53.57)	< .001

ISSN: 1471-2490